COA 2020: Effect of Liposomal Bupivacaine vs Ropivacaine in Interscalene Block for TSA patients
A Comparison of Liposomal Bupivacaine to Standard Ropivacaine Used in Interscalene Blocks for Patients Undergoing Total Shoulder Arthroplasty and the Effect on Postoperative Analgesia, Length of Hospitalization, and Functionality (COA HSP25)
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
One hundred and fifty-six patients undergoing total shoulder arthroplasty were included in this study comparing interscalene brachial plexus blockade with liposomal bupivacaine and ropivacaine or ropivacaine alone. Data was obtained from surgeries performed between June 1st 2017 and September 1st 2019. Outcomes of interest included post-operative pain scores, opioid consumption, length of hospital...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE